ProCE Banner Activity

CE / CME

Where We’re Going: The Next Wave of Antiretroviral Innovations

Podcast Episodes

Hear from global experts Ann Avery, MD; Isolde Butler, MD, MPH; Monica Gandhi, MD, MPH; Marissa Gonzalez; Angelina Namiba; and Chloe Orkin, MBChB, FRCP, MD, on how HIV care can better meet the diverse needs of people living with HIV as new treatment strategies emerge and continue to evolve.

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Pharmacists: 0.50 contact hour (0.05 CEUs)

Released: November 15, 2023

Expiration: November 14, 2024

Share

Faculty

Ann Avery

Ann Avery, MD

Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio

Jennifer Blanchette

Jennifer Blanchette, PhD

Independent Contractor
Clinical Care Options
Colorado, United States

Isolde F. Butler

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana 

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Marissa Gonzalez

Marissa Gonzalez

Chair 
Community Advisory Board 
The Well Project 

Angelina Namiba

Angelina Namiba

Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, physician associates/physician assistants, and other healthcare professionals who care for persons with HIV.

Program Learning Goal

The goal of this program is to improve learners’ knowledge and competence regarding the evolving field of HIV care including current best practices in HIV service delivery, the potential role of emerging ART options, and key concepts in HIV cure research.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify how the next wave of ART agents may enhance PWH satisfaction and treatment outcomes by providing additional options for individualized therapy

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Ann Avery, MD

Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio

Ann Avery, MD, has no relevant financial relationships to disclose.

Jennifer Blanchette, PhD

Independent Contractor
Clinical Care Options
Colorado, United States

Jennifer Blanchette, PhD, has no relevant financial relationships to disclose.

Isolde F. Butler, MD, MPH

Chief Medical Officer
Crescent Care
New Orleans, Louisiana 

Isolde F. Butler, MD, MPH, has no relevant financial relationships to disclose.

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.

Marissa Gonzalez,

Chair 
Community Advisory Board 
The Well Project 

Marissa Gonzalez has no relevant financial relationships to disclose.

Angelina Namiba,

Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Angelina Namiba, has no financial relationships to disclose.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, Merck Sharp & Dohme, ViiV.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from November 15, 2023, through November 14, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must respond to all evaluation questions to receive a certificate.  After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008176-0000-23-298-H02-P
Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.